Pharma stocks rally on lower price erosion, hopes of US generic mkt uptick

Pharma players with a major exposure to US mkt such as Sun Pharma, Lupin, Zydus Life, Dr Reddy's, Aurobindo, Torrent have been outperformers hitting their 52-week highs over the last couple of weeks

Pharma stocks, firms, earnings

Relief on the pricing front in the current portfolio is another positive

Ram Prasad Sahu

Listen to This Article

Healthcare stocks have outperformed the benchmark indices since the start of the current financial year. The BSE Healthcare Index is up 19 per cent as compared to BSE Sensex returns of 11 per cent during this period.

Nitin Agarwal of DAM Capital highlighted this trend in a report last month. “After a sustained period of underperformance over FY21-23, the BSE Healthcare Index has once again captured the spotlight. The recent uptick in performance has been driven by hospitals and emerging green shoots in pharmaceutical exports, particularly to the US, along with sustaining momentum in domestic branded formulations,” he said.

Within this space, pharma players with major exposure to the US market such as Sun Pharma, Lupin, Zydus Life, Dr Reddy’s,

First Published: Jul 04 2023 | 08:20 AM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on are available only to BS Premium subscribers.

Register to